TY - JOUR
KW - Ocular manifistations
KW - leprosy
KW - India
AU - Premanandam M
AU - Narendranatha Reddy G
AB - <div dir="ltr">From september 2012 to october 2013, during this period we have selected 100 leprosy patients as a samplefor study of ocular manifestions of leprosy. There people were living in leprosy colonies in kurnool,others were admitted in leprosy ward of Govt. General hospital kurnool,and leprosy patients attending regional eyehospital outpatient department.kurnool, in the juridiction of the kurnool medical college kurnool, Andrapradesh state. In our study of sample (61%) of leper's had ocular manifestations between the age group of 41-61’ years this is the maximum prevalence in our study. 78% leprosy patients were make predominance showndue to lepromatoues type of the disease (77.08%) patients had ocular manifestations. Age wise ( 41-61 year) 65.6% effected by ocular involument. With the infected period 6</div>

<div dir="ltr">- 10 year’s duration 69.38% shown ocular manifestations. In our further study of the sample ocular manifestations were as follows below madarosis 75.44%, lagophthalmus 39.44% cornel leasinons 44.28%, anterioruveitis 34.44, ectropion 11.48, lens changes 58.84% noticed respectively. In positive lepra reaction of 25 cases ocular involument were observed 41%. Regarding visual impairment 61 patients affected (</div>

<div dir="ltr">72.16%),</div>

<div dir="ltr">i)BCVA 6/36-CF3mts(U/L) 28 cases 45.92%</div>

<div dir="ltr">ii)BCVA6/36-CF3mts(B/L) 16 cases 26.24%</div>

<div dir="ltr">iii) BCVA&lt;CF 3mts (U/L) 5 cases of 8.2% shown visual impairment.</div>

<div dir="ltr">Remaining cases were bilateral cataract. And finally comparative study of ocular manifestions discused in table from.</div>

<div dir="ltr">According their ocular problems and systemic disease wise we refer the cases to the ophthalmology,dermatology, plasticsurgry, medicine departments respectively for further management.</div>

BT - Journal of Medical Science and Clinical Research
CN - PREMANANDAM2015
IS - 2
J2 - JMSCR
LA - eng
N2 - <div dir="ltr">From september 2012 to october 2013, during this period we have selected 100 leprosy patients as a samplefor study of ocular manifestions of leprosy. There people were living in leprosy colonies in kurnool,others were admitted in leprosy ward of Govt. General hospital kurnool,and leprosy patients attending regional eyehospital outpatient department.kurnool, in the juridiction of the kurnool medical college kurnool, Andrapradesh state. In our study of sample (61%) of leper's had ocular manifestations between the age group of 41-61’ years this is the maximum prevalence in our study. 78% leprosy patients were make predominance showndue to lepromatoues type of the disease (77.08%) patients had ocular manifestations. Age wise ( 41-61 year) 65.6% effected by ocular involument. With the infected period 6</div>

<div dir="ltr">- 10 year’s duration 69.38% shown ocular manifestations. In our further study of the sample ocular manifestations were as follows below madarosis 75.44%, lagophthalmus 39.44% cornel leasinons 44.28%, anterioruveitis 34.44, ectropion 11.48, lens changes 58.84% noticed respectively. In positive lepra reaction of 25 cases ocular involument were observed 41%. Regarding visual impairment 61 patients affected (</div>

<div dir="ltr">72.16%),</div>

<div dir="ltr">i)BCVA 6/36-CF3mts(U/L) 28 cases 45.92%</div>

<div dir="ltr">ii)BCVA6/36-CF3mts(B/L) 16 cases 26.24%</div>

<div dir="ltr">iii) BCVA&lt;CF 3mts (U/L) 5 cases of 8.2% shown visual impairment.</div>

<div dir="ltr">Remaining cases were bilateral cataract. And finally comparative study of ocular manifestions discused in table from.</div>

<div dir="ltr">According their ocular problems and systemic disease wise we refer the cases to the ophthalmology,dermatology, plasticsurgry, medicine departments respectively for further management.</div>

PY - 2015
SP - 4269
EP - 4276
T2 - Journal of Medical Science and Clinical Research
TI - A clinical study on ocular manifestations of leprosy.
UR - http://jmscr.igmpublication.org/v3-i2/31%20jmscr.pdf
VL - 3
ER -